The European Patent Office (EPO) has published a new patent application, EP2026030664A1, titled 'Methods for Selectively Targeting Neuronal Pathways'. This application, published on March 18, 2026, relates to biotechnology and specifically to methods for targeting neuronal pathways, with IPC classifications including C12N and C07K. The application covers designated states across Europe.

As this is a patent publication, it does not impose direct compliance obligations on regulated entities. However, companies in the pharmaceutical and biotechnology sectors, particularly those involved in drug development or neuroscience research, should be aware of this publication as it may indicate emerging technologies or areas of innovation. The inventor designation has not yet been filed, suggesting the application is still in its early stages.